A JUDGE`S decision last week in a generic drug dispute could return to haunt the Federal Trade Commission in future antitrust cases.
July 10, 2002 at 12:00 AM
1 minute read
A JUDGE’S decision last week in a generic drug dispute could return to haunt the Federal Trade Commission in future antitrust cases.
Administrative Law Judge D. Michael Chappell on July 2 cleared Schering-Plough Corp. and Upsher-Smith Laboratories of charges that they violated antitrust law by agreeing to delay commercial introduction of a generic drug.
Presented by BigVoodoo
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
